广发纳斯达克生物科技人民币(001092)
动态评分: 5.86分
投资组合

报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
2024-06-30 | ALNY | Alnylam Pharmaceuticals Inc | 买入 | 14.97 | 0.1% |
2024-06-30 | RNA | Avidity Biosciences Inc | 买入 | 13.43 | 0.09% |
2024-06-30 | ITCI | Intra-Cellular Therapies Inc | 买入 | 11.48 | 0.08% |
2024-06-30 | MRNA | Moderna Inc | 买入 | 11.32 | 0.08% |
2024-06-30 | ICVX US | Icosavax Inc | 卖出 | 10.19 | 0.07% |
2024-06-30 | NBIX | 神经分泌生物科学 | 买入 | 9.72 | 0.07% |
2024-06-30 | GRCL US | Gracell Biotechnologies Inc | 卖出 | 9.81 | 0.07% |
2024-06-30 | MDGL | Madrigal Pharmaceuticals Inc | 买入 | 8.29 | 0.06% |
2024-06-30 | MRUS | Merus NV | 买入 | 8.22 | 0.06% |
2024-06-30 | CRNX | Crinetics Pharmaceuticals Inc | 买入 | 8.44 | 0.06% |
2024-06-30 | BMRN | 拜玛林制药 | 买入 | 7.69 | 0.05% |
2024-06-30 | EWTX | Edgewise Therapeutics Inc | 买入 | 7.95 | 0.05% |
2024-06-30 | OCUL | Ocular Therapeutix Inc | 买入 | 7.81 | 0.05% |
2024-06-30 | SWTX | SpringWorks Therapeutics Inc | 买入 | 7.84 | 0.05% |
2024-06-30 | SRPT | Sarepta Therapeutics Inc | 买入 | 7.76 | 0.05% |
2024-06-30 | ROIV | Roivant Sciences Ltd | 卖出 | 6.37 | 0.04% |
2024-06-30 | UTHR | 联合治疗 | 卖出 | 6.16 | 0.04% |
2024-06-30 | APGE | Apogee Therapeutics Inc | 卖出 | 3.87 | 0.03% |
2024-06-30 | EXEL | 伊克力西斯 | 卖出 | 3.54 | 0.02% |
2024-06-30 | RNAC | Cartesian Therapeutics Inc | 卖出 | 1.2 | 0.01% |
公告&资料
